Follow-on roundup: Synageva, Five Prime, Cerus

Shares of Synageva BioPharma Corp. (NASDAQ:GEVA), Five Prime Therapeutics Inc. (NASDAQ:FPRX) and Cerus Corp. (NASDAQ:CERS) all rose on Wednesday after the companies raised a total of $427.6 million in follow-ons.

Rare disease play Synageva raised $282.6 million through the sale of

Read the full 416 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE